Procter & Gamble Hygiene & Health Care Ltd. Stock Hits 52-Week Low at Rs.11,466.1

Stock Price Movement and Market Context

The stock of Procter & Gamble Hygiene & Health Care Ltd. (Stock ID: 927063) touched Rs.11466.1 today, representing its lowest level in the past year. This decline comes after three consecutive days of losses, during which the stock has fallen by 3.17%. Despite this downward trend, the stock marginally outperformed its sector by 0.52% on the day of the new low.

Currently, the stock is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained downward momentum. This contrasts with the broader market, where the Sensex opened lower at 82,902.73, down 772.19 points (-0.92%), and is trading near 82,927.65 (-0.89%). The Sensex remains 3.9% below its 52-week high of 86,159.02, with its 50-day moving average positioned above the 200-day moving average, indicating a mixed technical backdrop.

Financial Performance and Valuation Metrics

Over the last year, Procter & Gamble Hygiene & Health Care Ltd. has underperformed the benchmark Sensex, delivering a negative return of -16.87% compared to the Sensex’s positive 8.92% gain. The stock’s 52-week high was Rs.14,536.6, highlighting the extent of the recent decline.

Long-term growth rates have been modest, with net sales increasing at an annual rate of 5.52% and operating profit growing at 5.34% over the past five years. Despite this, the company reported positive quarterly results in December 2025, with net sales reaching a quarterly high of Rs.1,261.90 crore and PBDIT at Rs.401.80 crore. The operating profit margin to net sales also peaked at 31.84% during this period.

Valuation and Efficiency Considerations

The company’s return on equity (ROE) stands at a notably high 81.87%, reflecting strong management efficiency in generating profits from shareholder equity. However, the stock’s valuation appears stretched, with a price-to-book value of 40.6, indicating a very expensive valuation relative to its book value. This valuation is discounted compared to the average historical valuations of its peers in the FMCG sector.

Despite the high ROE, the PEG ratio of 2.2 suggests that the stock’s price growth is not fully aligned with its earnings growth, which rose by 20.1% over the past year. The company maintains a low average debt-to-equity ratio of zero, underscoring a conservative capital structure with minimal leverage.

Performance Relative to Benchmarks and Peers

Procter & Gamble Hygiene & Health Care Ltd. has consistently underperformed the BSE500 index over the last three annual periods. The stock’s negative return of -16.87% in the past year further emphasises this trend of underperformance against broader market indices and sector peers.

Majority ownership remains with promoters, providing stability in shareholding patterns. The company operates within the FMCG sector, which has seen mixed performance in recent months, with some stocks demonstrating resilience while others face pressure from valuation concerns and market volatility.

Dividend Yield and Investor Returns

At the current price level, Procter & Gamble Hygiene & Health Care Ltd. offers a dividend yield of 3.18%, which is relatively attractive within the FMCG sector. This yield provides a degree of income return amid the stock’s price decline.

However, the stock’s recent price trajectory and valuation metrics reflect a cautious market stance. The combination of modest sales growth, high valuation multiples, and consistent underperformance relative to benchmarks has contributed to the stock’s slide to its 52-week low.

Summary of Key Metrics

To summarise, the stock’s key data points as of 13 Feb 2026 include:

• New 52-week low price: Rs.11466.1
• Three-day consecutive decline: -3.17%
• Mojo Score: 43.0 with a Sell grade (downgraded from Hold on 17 Oct 2024)
• Market Cap Grade: 2
• Return on Equity: 81.87%
• Price to Book Value: 40.6
• PEG Ratio: 2.2
• Dividend Yield: 3.18%
• Debt to Equity Ratio: 0 (average)

These figures reflect a stock that is currently trading at a discount to its historical highs but remains expensive on valuation metrics, with mixed signals from financial performance and market positioning.

Broader Market and Sector Environment

The FMCG sector, in which Procter & Gamble Hygiene & Health Care Ltd. operates, has experienced varied performance across its constituents. While some companies have benefited from steady demand and pricing power, others face valuation pressures and slower growth trajectories. The Sensex’s recent weakness and proximity to its 52-week high add context to the stock’s price movements, highlighting the selective nature of market gains and losses.

Conclusion

Procter & Gamble Hygiene & Health Care Ltd.’s fall to a 52-week low of Rs.11466.1 underscores the challenges faced by the stock in maintaining upward momentum amid valuation concerns and relative underperformance. The company’s strong management efficiency and low leverage contrast with its modest sales growth and high valuation multiples. These factors collectively contribute to the current market assessment and price levels.

Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →